Home Healthcare Pharmaceuticals Antibody Drug Conjugates Market

Antibody Drug Conjugates Market Size, Share & Trends Analysis Report By Product Type (Adcetris, Kadcyla, Enhertu, Padcev, Trodelvy, Others), By Application (Blood Cancer, Breast Cancer, Urothelial Cancer, Lung Cancer, Others), By Target (CD33, HER2, CD30, TROP2, Others) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 24, 2026 | Author: Mitiksha Koul | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Antibody Drug Conjugates Market Size Analysis
    1. Introduction
    2. Antibody Drug Conjugates Market Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
      1. Adcetris
      2. Kadcyla
      3. Enhertu
      4. Padcev
      5. Trodelvy
      6. Others
    3. Antibody Drug Conjugates Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Blood Cancer
      2. Breast Cancer
      3. Urothelial Cancer
      4. Lung Cancer
      5. Others
    4. Antibody Drug Conjugates Market Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
      1. CD33
      2. HER2
      3. CD30
      4. TROP2
      5. Others
  7. North America Antibody Drug Conjugates Market Size Analysis
    1. Introduction
    2. Antibody Drug Conjugates Market Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
      1. Adcetris
      2. Kadcyla
      3. Enhertu
      4. Padcev
      5. Trodelvy
      6. Others
    3. Antibody Drug Conjugates Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Blood Cancer
      2. Breast Cancer
      3. Urothelial Cancer
      4. Lung Cancer
      5. Others
    4. Antibody Drug Conjugates Market Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
      1. CD33
      2. HER2
      3. CD30
      4. TROP2
      5. Others
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
  8. Europe Antibody Drug Conjugates Market Size Analysis
    1. Introduction
    2. Antibody Drug Conjugates Market Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
      1. Adcetris
      2. Kadcyla
      3. Enhertu
      4. Padcev
      5. Trodelvy
      6. Others
    3. Antibody Drug Conjugates Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Blood Cancer
      2. Breast Cancer
      3. Urothelial Cancer
      4. Lung Cancer
      5. Others
    4. Antibody Drug Conjugates Market Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
      1. CD33
      2. HER2
      3. CD30
      4. TROP2
      5. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
  9. APAC Antibody Drug Conjugates Market Size Analysis
    1. Introduction
    2. Antibody Drug Conjugates Market Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
      1. Adcetris
      2. Kadcyla
      3. Enhertu
      4. Padcev
      5. Trodelvy
      6. Others
    3. Antibody Drug Conjugates Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Blood Cancer
      2. Breast Cancer
      3. Urothelial Cancer
      4. Lung Cancer
      5. Others
    4. Antibody Drug Conjugates Market Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
      1. CD33
      2. HER2
      3. CD30
      4. TROP2
      5. Others
    5. China
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    8. India
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
  10. Middle East and Africa Antibody Drug Conjugates Market Size Analysis
    1. Introduction
    2. Antibody Drug Conjugates Market Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
      1. Adcetris
      2. Kadcyla
      3. Enhertu
      4. Padcev
      5. Trodelvy
      6. Others
    3. Antibody Drug Conjugates Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Blood Cancer
      2. Breast Cancer
      3. Urothelial Cancer
      4. Lung Cancer
      5. Others
    4. Antibody Drug Conjugates Market Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
      1. CD33
      2. HER2
      3. CD30
      4. TROP2
      5. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
  11. LATAM Antibody Drug Conjugates Market Size Analysis
    1. Introduction
    2. Antibody Drug Conjugates Market Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
      1. Adcetris
      2. Kadcyla
      3. Enhertu
      4. Padcev
      5. Trodelvy
      6. Others
    3. Antibody Drug Conjugates Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Blood Cancer
      2. Breast Cancer
      3. Urothelial Cancer
      4. Lung Cancer
      5. Others
    4. Antibody Drug Conjugates Market Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
      1. CD33
      2. HER2
      3. CD30
      4. TROP2
      5. Others
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product Type 2022-2034 (USD MILLION/ Units)
        1. Adcetris
        2. Kadcyla
        3. Enhertu
        4. Padcev
        5. Trodelvy
        6. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Blood Cancer
        2. Breast Cancer
        3. Urothelial Cancer
        4. Lung Cancer
        5. Others
      4. Market Size & Forecast By Target 2022-2034 (USD MILLION/ Units)
        1. CD33
        2. HER2
        3. CD30
        4. TROP2
        5. Others
  12. Competitive Landscape
    1. Antibody Drug Conjugates Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Hoffmann-La Roche Ltd.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Daiichi Sankyo
    3. Pfizer Inc.
    4. Gilead Sciences
    5. AstraZeneca
    6. AbbVie Inc.
    7. ADC Therapeutics
    8. Genmab A/S
    9. Astellas Pharma Inc.
    10. RemeGen Co., Ltd.
    11. GSK plc
    12. Takeda Pharmaceuticals
    13. Hansoh Pharmaceutical Group Company Limited.
    14. Eli Lilly and Company
    15. Bristol-Myers Squibb Company
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.